[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018更新版). 实用肝脏病杂志 2018, 21(2):177-186.
[2] Fan JG, Kim SU, Wong Vincent WS. New trends on obesity and NAFLD in Asia. J Hepatol, 2017, 67:862-873.
[3] Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol, 2018, 15(1):11-20.
[4] Lonardo A, Nascimbeni F, Mantovani A, et al. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? J Hepatol, 2018, 68(2):335-352.
[5] Debes JD, Boonstra A, de Knegt RJ. NAFLD-related hepatocellular carcinoma and the four horsemen of the apocalypse. Hepatology, 2020, 71(3):774-776.
[6] Simon TG, Kim MN, Luo X, et al. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020.
[7] Kanwal F, Kramer JR, Mapakshi S, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology, 2018, 155(6):1828-1837.e2.
[8] 杨菁,范建高. 肥胖通过不同机制导致脂肪性肝炎和肝细胞癌. 肝脏,2019,24:1375-1376. |
